AI-generated summary
The authors reviewed 21 studies of low-level laser therapy for hair loss, including 2 in vitro, 7 animal and 12 clinical studies, of which 5 were randomized controlled trials. They report that the randomized trials had moderate to high quality of evidence but that reporting was often incomplete, such as limited intention-to-treat analysis and unclear randomization methods. They conclude that FDA-cleared devices appear safe and effective for male and female pattern hair loss in patients who did not respond to standard treatments.
- Studies included
- 21
- Who or what was studied
- Individuals with hair loss, including male pattern hair loss, female pattern hair loss, alopecia areata and chemotherapy-induced alopecia
- Limits stated in the abstract
- The abstract notes that only five randomized trials were included and that most lacked intention-to-treat analysis, clear randomization reporting and number-needed-to-treat data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Intention-to-treat analysis, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.